valine has been researched along with Coronary Heart Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 13 (72.22) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, A; Furukawa, Y; Furuta, H; Kusuyama, A; Matsuno, S; Nanjo, K; Nishi, M; Sanke, T; Sasaki, H; Shimada, T; Yasuda, K | 1 |
| Yui, Y | 1 |
| Heng, CK; Low, PS; Saha, N; Tan, JH; Tan, YS; Tong, MC; Yang, H | 1 |
| Hukai, D; Ishii, C; Kanamori, T; Ohbayashi, Y; Ohnishi, M; Ohno, K; Okabayashi, T; Ozawa, T; Sakaguchi, T; Sichiri, G; Tanaka, T; Tsutamoto, T; Tsutsui, T; Wada, A; Yokohama, H | 1 |
| Liebson, PR | 1 |
| Cheung, BM | 1 |
| Dahlöf, B; Ikewaki, K; Kanae, K; Kawai, M; Mochizuki, S; Ogawa, K; Ohta, M; Okazaki, F; Seki, S; Shimizu, M; Tajima, N; Taniguchi, I; Taniguchi, M; Yamada, T; Yoshida, S; Yoshikawa, M | 1 |
| Barrio, JR; Baumgartner, FJ; Egbert, JE; Henze, E; Liu, FT; MacDonald, NS; Phelps, ME; Schelbert, HR; Stauber, MS | 1 |
| Evans, A; Gallagher, PM; Graham, IM; McMaster, D; Meleady, R; Rozen, R; Shields, DC; Tan, KS; Whitehead, AS | 1 |
| Arveiler, D; Aumont, MC; de Prost, D; Desprez, S; Dhermy, D; Evans, A; Fumeron, F; Galand, C; Garbarz, M; Hakim, J; Luc, G; Moatti, D; Ollivier, V; Poirier, O; Ruidavets, JB; Seknadji, P | 1 |
| Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Gulba, D; Haller, H; Luft, FC; Luther, T; Mackman, N; Mervaala, EM; Müller, DN; Park, JK; Schmidt, F; Schneider, W; Theuer, J | 1 |
| Ellis, SG | 1 |
| Brattström, A; Götting, B; Peters, S; Rust, H; Trümmel, M | 1 |
| Kulbertus, H | 1 |
| Casado, S; Gómez, J; Jiménez, A; Lopez-Bloya, A; López-Farré, A; Montón, M; Núñez, A; Rico, L; Sánchez de Miguel, L | 1 |
| Brunner, H; Ekman, S; Hansson, L; Henis, M; Julius, S; Kjeldsen, SE; Laragh, J; McInnes, G; Smith, B; Weber, M; Zanchetti, A | 1 |
| Hinterberger, U; Kleitke, B; Onnen, K; Rabitzsch, G; Wollenberger, A | 1 |
3 review(s) available for valine and Coronary Heart Disease
| Article | Year |
|---|---|
Therapeutic potential of angiotensin receptor blockers in hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Disease; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Survival Analysis; Tetrazoles; Valine; Valsartan | 2006 |
Angiotensin II AT(1) receptor antagonists and platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Thrombosis; Humans; Losartan; P-Selectin; Platelet Activation; Platelet Aggregation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Thromboxane; Tetrazoles; Thrombosis; Thromboxane A2; Valine; Valsartan | 2001 |
Myocardial protein synthesis in acute myocardial hypoxia and ischemia.
Topics: Adenosine Triphosphate; Animals; Autolysis; Carbon Isotopes; Cell-Free System; Coronary Disease; Heart Atria; Hypoxia; In Vitro Techniques; Kinetics; Leucine; Microscopy, Electron; Mitochondria, Muscle; Muscle Proteins; Myocardium; Oxygen Consumption; Phenylalanine; Pressure; Rats; Ribosomes; RNA; Sucrose; Valine | 1971 |
4 trial(s) available for valine and Coronary Heart Disease
| Article | Year |
|---|---|
Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Coronary Disease; Delayed-Action Preparations; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Valine; Valsartan | 2003 |
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Coronary Disease; Endpoint Determination; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Japan; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2007 |
Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagonists; Antihypertensive Agents; Coronary Disease; Female; Humans; Male; Middle Aged; Recurrence; Stents; Tetrazoles; Valine; Valsartan | 2001 |
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation.
Topics: Aged; Aged, 80 and over; Algorithms; Antihypertensive Agents; Clinical Protocols; Coronary Disease; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Tetrazoles; Valine; Valsartan | 2001 |
11 other study(ies) available for valine and Coronary Heart Disease
| Article | Year |
|---|---|
SUMO4 Met55Val polymorphism is associated with coronary heart disease in Japanese type 2 diabetes individuals.
Topics: Aged; Amino Acid Substitution; Autoantibodies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Genetic Predisposition to Disease; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Japan; Male; Methionine; Middle Aged; Reference Values; Small Ubiquitin-Related Modifier Proteins; Valine | 2009 |
Concerns about the Jikei Heart Study.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Coronary Disease; Endpoint Determination; Female; Heart Failure; Humans; Hypertension; Male; Tetrazoles; Valine | 2012 |
ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore.
Topics: Alanine; Apolipoprotein A-I; Asian People; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cysteine; Genotype; Glycine; Haplotypes; Humans; India; Isoleucine; Linkage Disequilibrium; Lipids; Malaysia; Male; Methionine; Polymorphism, Genetic; Sequence Analysis, DNA; Singapore; Threonine; Triglycerides; Valine; White People | 2003 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
[Convincing results from the JIKEI Study].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Controlled Clinical Trials as Topic; Coronary Disease; Heart Failure; Humans; Hypertension; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
Synthesis and myocardial kinetics of N-13 and C-11 labeled branched-chain L-amino acids.
Topics: Amino Acids, Branched-Chain; Animals; Carbon Radioisotopes; Coronary Disease; Dogs; Enzymes, Immobilized; Glutamate Dehydrogenase; Hydrogen-Ion Concentration; Kinetics; Leucine; Myocardium; Nitrogen Radioisotopes; Transaminases; Valine | 1983 |
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.
Topics: Alanine; Alleles; Coronary Disease; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Temperature; Valine | 1996 |
Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.
Topics: Acute Disease; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Angina, Unstable; Case-Control Studies; Coronary Disease; France; Gene Frequency; Genotype; Humans; Lipoproteins; Male; Methionine; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Syndrome; Valine | 1999 |
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Coagulation Factors; Blood Pressure; Cell Line; CHO Cells; Coronary Disease; Coronary Vessels; Cricetinae; Extracellular Matrix Proteins; Heart Ventricles; Humans; Inflammation; Integrin alpha4beta1; Integrins; NF-kappa B; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Lymphocyte Homing; RNA, Messenger; Tetrazoles; Thromboplastin; Transcription Factor AP-1; Valine; Valsartan; Vascular Resistance | 2000 |
Do ACE inhibitors or ARBs limit restenosis after stenting? --assimilating the data.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Coronary Disease; Humans; Recurrence; Tetrazoles; Valine; Valsartan | 2001 |
[Info-congress. COPERNICUS and Val-HEFT studies].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Coronary Disease; Heart Failure; Humans; Propanolamines; Randomized Controlled Trials as Topic; Survival Analysis; Tetrazoles; Valine; Valsartan | 2000 |